The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases

Aleksandr Vitalyevich Volkov, T V Martynyuk, N N Yudkina, N M Danilov, T M Reshetnyak, I E Chazova, E L Nasonov
2011 Naučno-Praktičeskaâ Revmatologiâ  
doi:10.14412/1995-4484-2011-515 fatcat:uxje6wap65f27futvadhnka25q